<--- Back to Details
First PageDocument Content
Mucopolysaccharidosis / Hurler syndrome / Iduronidase / Lysosomal storage disease / Coarse facial features / BioMarin Pharmaceutical / Enzyme replacement therapy / Hurler–Scheie syndrome / Methadone / Health / Syndromes / Medicine
Mucopolysaccharidosis
Hurler syndrome
Iduronidase
Lysosomal storage disease
Coarse facial features
BioMarin Pharmaceutical
Enzyme replacement therapy
Hurler–Scheie syndrome
Methadone
Health
Syndromes
Medicine

Review - Laronidase (Aldurazyme)

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 392,83 KB

Share Document on Facebook

Similar Documents

Implantação de um protocolo laboratorial para o diagnóstico de Mucopolissacaridoses VI e VII* Evaluation of a laboratorial protocol for Mucopolysaccharidosis VI and VII Gustavo Monteiro VIANA1; Camila de Britto Ponte

DocID: 1v8Z4 - View Document

What is HUNTER SYNDROME? Hunter syndrome, or mucopolysaccharidosis II (MPS II), is a rare and progressive lysosomal storage disease inherited in an X-linked recessive

DocID: 1lIxr - View Document

Mucopolysaccharidosis / Hunter syndrome / Hurler syndrome / Morquio syndrome / Sanfilippo syndrome / Maroteaux–Lamy syndrome / Genetic disorder / Lysosomal storage disease / Sly syndrome / Health / Syndromes / Rare diseases

MUCOPOLYSACCHARIDOSES Rare Diseases Unit of the Finnish Association of People with Physical Disabilities Support for this guide was provided by Genzyme.

DocID: 1fJSQ - View Document

Genetic genealogy / BioMarin Pharmaceutical / Glycogen storage disease type II / Acid alpha-glucosidase / Lysosomal storage disease / Mucopolysaccharidosis / Alglucosidase alfa / Neuronal ceroid lipofuscinosis / Tetrahydrobiopterin / Health / Rare diseases / Medicine

May 27, 2014 BioMarin Doses First Patient in Phase 3 INSPIRE Trial With BMN 701 for the Treatment of Pompe Disease Proprietary Glycosylation Independent Lysosomal Targeting (GILT) Tagging Technology Has Been Shown to Im

DocID: 1aiEg - View Document

BioMarin Pharmaceutical / Rare diseases / Orphan drugs / Lysosomal storage diseases / Glycogen storage disease type II / Mucopolysaccharidosis / Mannose 6-phosphate / Hurler syndrome / Phenylketonuria / Health / Medicine / Genetic genealogy

Microsoft Word - Apjohn Ventures Fund 2Q10 Letter Final

DocID: 19Qom - View Document